• レポートコード:GIR-22E3597 • 出版社/出版日:GlobalInfoResearch / 2022年5月 • レポート形態:英文、PDF、104ページ • 納品方法:Eメール(2~3営業日) • 産業分類:消費財 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
ニコチンガム&トローチ市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のニコチンガム&トローチの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。 ニコチンガム&トローチ市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・2mg /個、4mg /個、その他 用途別セグメントは次のように区分されます。 ・クリニック退院、医療行為、個人喫煙者、その他 世界のニコチンガム&トローチ市場の主要な市場プレーヤーは以下のとおりです。 ・Novartis、Perrigo Company、Pharmacia、Fertin Pharma、Revolymer、Johnson & Johnson、Alchem International、Cambrex Corporation、GlaxoSmithKline、Reynolds American、Dr. Reddy's Laboratories 地域別セグメントは次の地域・国をカバーします。 ・北米(米国、カナダ、メキシコ) ・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア) ・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア) ・南アメリカ(ブラジル、アルゼンチン、コロンビア) ・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ) 本調査レポートの内容は計15章あります。 ・第1章では、ニコチンガム&トローチ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なニコチンガム&トローチメーカーの企業概要、2019年~2022年までのニコチンガム&トローチの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なニコチンガム&トローチメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年~2028年までの地域別ニコチンガム&トローチの販売量、売上、成長性を示しています。 ・第5、6章では、2017年~2028年までのニコチンガム&トローチの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのニコチンガム&トローチ市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびニコチンガム&トローチの産業チェーンを掲載しています。 ・第13、14、15章では、ニコチンガム&トローチの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報(企業概要、製品概要、販売量、価格、売上):Novartis、Perrigo Company、Pharmacia、Fertin Pharma、Revolymer、Johnson & Johnson、Alchem International、Cambrex Corporation、GlaxoSmithKline、Reynolds American、Dr. Reddy's Laboratories ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年:2mg /個、4mg /個、その他 ・用途別分析2017年-2028年:クリニック退院、医療行為、個人喫煙者、その他 ・ニコチンガム&トローチの北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ ・ニコチンガム&トローチのヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア ・ニコチンガム&トローチのアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア ・ニコチンガム&トローチの南米市場規模2017年-2028年:ブラジル、アルゼンチン ・ニコチンガム&トローチの中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Nicotine Gums and Lozenges market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nicotine Gums and Lozenges market size is estimated to be worth US$ 404.4 million in 2021 and is forecast to a readjusted size of USD 604.2 million by 2028 with a CAGR of 5.9% during review period. Withdrawal Clinics accounting for % of the Nicotine Gums and Lozenges global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 2 mg/piece segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nicotine Gums and Lozenges include Novartis, Perrigo Company, Pharmacia, Fertin Pharma, and Revolymer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nicotine Gums and Lozenges market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
2 mg/piece
4 mg/piece
Other
Market segment by Application can be divided into
Withdrawal Clinics
Medical Practice
Individual Smokers
Others
The key market players for global Nicotine Gums and Lozenges market are listed below:
Novartis
Perrigo Company
Pharmacia
Fertin Pharma
Revolymer
Johnson & Johnson
Alchem International
Cambrex Corporation
GlaxoSmithKline
Reynolds American
Dr. Reddy’s Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotine Gums and Lozenges product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nicotine Gums and Lozenges, with price, sales, revenue and global market share of Nicotine Gums and Lozenges from 2019 to 2022.
Chapter 3, the Nicotine Gums and Lozenges competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotine Gums and Lozenges breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nicotine Gums and Lozenges market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nicotine Gums and Lozenges.
Chapter 13, 14, and 15, to describe Nicotine Gums and Lozenges sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Nicotine Gums and Lozenges Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nicotine Gums and Lozenges Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 2 mg/piece
1.2.3 4 mg/piece
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Nicotine Gums and Lozenges Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Withdrawal Clinics
1.3.3 Medical Practice
1.3.4 Individual Smokers
1.3.5 Others
1.4 Global Nicotine Gums and Lozenges Market Size & Forecast
1.4.1 Global Nicotine Gums and Lozenges Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nicotine Gums and Lozenges Sales in Volume (2017-2028)
1.4.3 Global Nicotine Gums and Lozenges Price (2017-2028)
1.5 Global Nicotine Gums and Lozenges Production Capacity Analysis
1.5.1 Global Nicotine Gums and Lozenges Total Production Capacity (2017-2028)
1.5.2 Global Nicotine Gums and Lozenges Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nicotine Gums and Lozenges Market Drivers
1.6.2 Nicotine Gums and Lozenges Market Restraints
1.6.3 Nicotine Gums and Lozenges Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Nicotine Gums and Lozenges Product and Services
2.1.4 Novartis Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Perrigo Company
2.2.1 Perrigo Company Details
2.2.2 Perrigo Company Major Business
2.2.3 Perrigo Company Nicotine Gums and Lozenges Product and Services
2.2.4 Perrigo Company Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pharmacia
2.3.1 Pharmacia Details
2.3.2 Pharmacia Major Business
2.3.3 Pharmacia Nicotine Gums and Lozenges Product and Services
2.3.4 Pharmacia Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Fertin Pharma
2.4.1 Fertin Pharma Details
2.4.2 Fertin Pharma Major Business
2.4.3 Fertin Pharma Nicotine Gums and Lozenges Product and Services
2.4.4 Fertin Pharma Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Revolymer
2.5.1 Revolymer Details
2.5.2 Revolymer Major Business
2.5.3 Revolymer Nicotine Gums and Lozenges Product and Services
2.5.4 Revolymer Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Nicotine Gums and Lozenges Product and Services
2.6.4 Johnson & Johnson Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Alchem International
2.7.1 Alchem International Details
2.7.2 Alchem International Major Business
2.7.3 Alchem International Nicotine Gums and Lozenges Product and Services
2.7.4 Alchem International Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Cambrex Corporation
2.8.1 Cambrex Corporation Details
2.8.2 Cambrex Corporation Major Business
2.8.3 Cambrex Corporation Nicotine Gums and Lozenges Product and Services
2.8.4 Cambrex Corporation Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline Nicotine Gums and Lozenges Product and Services
2.9.4 GlaxoSmithKline Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Reynolds American
2.10.1 Reynolds American Details
2.10.2 Reynolds American Major Business
2.10.3 Reynolds American Nicotine Gums and Lozenges Product and Services
2.10.4 Reynolds American Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Dr. Reddy’s Laboratories
2.11.1 Dr. Reddy’s Laboratories Details
2.11.2 Dr. Reddy’s Laboratories Major Business
2.11.3 Dr. Reddy’s Laboratories Nicotine Gums and Lozenges Product and Services
2.11.4 Dr. Reddy’s Laboratories Nicotine Gums and Lozenges Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nicotine Gums and Lozenges Breakdown Data by Manufacturer
3.1 Global Nicotine Gums and Lozenges Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nicotine Gums and Lozenges Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nicotine Gums and Lozenges
3.4 Market Concentration Rate
3.4.1 Top 3 Nicotine Gums and Lozenges Manufacturer Market Share in 2021
3.4.2 Top 6 Nicotine Gums and Lozenges Manufacturer Market Share in 2021
3.5 Global Nicotine Gums and Lozenges Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nicotine Gums and Lozenges Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nicotine Gums and Lozenges Market Size by Region
4.1.1 Global Nicotine Gums and Lozenges Sales in Volume by Region (2017-2028)
4.1.2 Global Nicotine Gums and Lozenges Revenue by Region (2017-2028)
4.2 North America Nicotine Gums and Lozenges Revenue (2017-2028)
4.3 Europe Nicotine Gums and Lozenges Revenue (2017-2028)
4.4 Asia-Pacific Nicotine Gums and Lozenges Revenue (2017-2028)
4.5 South America Nicotine Gums and Lozenges Revenue (2017-2028)
4.6 Middle East and Africa Nicotine Gums and Lozenges Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nicotine Gums and Lozenges Sales in Volume by Type (2017-2028)
5.2 Global Nicotine Gums and Lozenges Revenue by Type (2017-2028)
5.3 Global Nicotine Gums and Lozenges Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nicotine Gums and Lozenges Sales in Volume by Application (2017-2028)
6.2 Global Nicotine Gums and Lozenges Revenue by Application (2017-2028)
6.3 Global Nicotine Gums and Lozenges Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nicotine Gums and Lozenges Sales by Type (2017-2028)
7.2 North America Nicotine Gums and Lozenges Sales by Application (2017-2028)
7.3 North America Nicotine Gums and Lozenges Market Size by Country
7.3.1 North America Nicotine Gums and Lozenges Sales in Volume by Country (2017-2028)
7.3.2 North America Nicotine Gums and Lozenges Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nicotine Gums and Lozenges Sales by Type (2017-2028)
8.2 Europe Nicotine Gums and Lozenges Sales by Application (2017-2028)
8.3 Europe Nicotine Gums and Lozenges Market Size by Country
8.3.1 Europe Nicotine Gums and Lozenges Sales in Volume by Country (2017-2028)
8.3.2 Europe Nicotine Gums and Lozenges Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nicotine Gums and Lozenges Sales by Type (2017-2028)
9.2 Asia-Pacific Nicotine Gums and Lozenges Sales by Application (2017-2028)
9.3 Asia-Pacific Nicotine Gums and Lozenges Market Size by Region
9.3.1 Asia-Pacific Nicotine Gums and Lozenges Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nicotine Gums and Lozenges Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nicotine Gums and Lozenges Sales by Type (2017-2028)
10.2 South America Nicotine Gums and Lozenges Sales by Application (2017-2028)
10.3 South America Nicotine Gums and Lozenges Market Size by Country
10.3.1 South America Nicotine Gums and Lozenges Sales in Volume by Country (2017-2028)
10.3.2 South America Nicotine Gums and Lozenges Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nicotine Gums and Lozenges Sales by Type (2017-2028)
11.2 Middle East & Africa Nicotine Gums and Lozenges Sales by Application (2017-2028)
11.3 Middle East & Africa Nicotine Gums and Lozenges Market Size by Country
11.3.1 Middle East & Africa Nicotine Gums and Lozenges Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nicotine Gums and Lozenges Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nicotine Gums and Lozenges and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nicotine Gums and Lozenges
12.3 Nicotine Gums and Lozenges Production Process
12.4 Nicotine Gums and Lozenges Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nicotine Gums and Lozenges Typical Distributors
13.3 Nicotine Gums and Lozenges Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer